AMA’s new president argues against federal budget cuts at the group’s annual policy meeting, where physicians oppose RFK Jr’s vaccine panel dismissals and call for greater AI transparency.

Recent studies assessed artificial intelligence (AI) assistance tools in their ability to provide quality medical recommendations for patients.

Tempus will use its "Lens" data analytics platform to analyze and restructure genomic data from the the Abrams Research Center.

The American Medical Association has established a new policy that aims to increase transparency and trust in AI tools used in clinical care. The policy was approved during the AMA’s annual meeting ...

When two of medicine’s most outspoken reformers publish a roadmap for the FDA, you expect at least coherence. Instead, we get ...

Cardioneurology, the intersection of cardiac and neurological sciences, has become increasingly important due to the complex ...

There’s no shortage of big promises about AI in healthcare. The U.S. government announced a $500 billion Stargate initiative ...

The integration of Artificial Intelligence (AI) in various sectors has been nothing short of transformative, and now, it’s poised to ...

Volta Medical announced a labeling update for its Volta AF-Xplorer decision support system following the publication of ...

Penny stocks captivate investors with their low prices. The allure of controlling large numbers of shares for relatively very ...

Recursion's AI-enabled drug discovery platform continues to evolve, but this is yet to translate into meaningful clinical ...

AI will greatly lessen the effort of the discovery process, bringing more novel therapies to the forefront faster than ever ...